Receptor-targeted delivery of an intracellular toxin to outer hair cells by fibroblast growth factor

被引:15
作者
Dazert, S
Baird, A
Ryan, AF
机构
[1] Univ Calif San Diego, Sch Med, Dept Surg Otolaryngol, La Jolla, CA 92093 USA
[2] Vet Adm Med Ctr, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Sch Med, Dept Neurosci, San Diego, CA 92121 USA
[4] Vet Adm Med Ctr, San Diego, CA 92121 USA
[5] Prizm Pharmaceut, San Diego, CA 92121 USA
关键词
inner ear; organ of Corti; hair cell; development; fibroblast growth factor; fibroblast growth factor receptor; saporin;
D O I
10.1016/S0378-5955(97)00188-3
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
The presence and distribution of functional, high-affinity receptors for fibroblast growth factors (FGFs) in the neonatal organ of Corti were probed using the intracellular toxin saporin conjugated to basic FGF (FGF-2). FGFs that bind to high-affinity FGF receptors are internalized as part of the normal process of receptor inactivation. The receptor can thus be used for the targeted delivery of molecules conjugated to FGF into the cytoplasm. Incubation of postnatal day 5 (P5) rat organ of Corti cultures with FGF-saporin caused a dose dependent destruction of outer hair cells, Deiters cells and outer pillar cells. Inner hair cells and other cells were unaffected. Organ of Corti cultures at P0 and P10 showed much less damage than at P5. The results suggest that outer hair cells and adjacent supporting cells in the organ of Corti transiently express high-affinity FGF receptors, and that these receptors can mediate the intracellular delivery of bioactive molecules. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 33 条
  • [1] BAIRD A, 1985, LANCET, V2, P563
  • [2] Baird Andrew, 1994, Current Opinion in Neurobiology, V4, P78, DOI 10.1016/0959-4388(94)90035-3
  • [3] SELECTIVE ELIMINATION OF FIBROBLASTS FROM PANCREATIC-ISLET MONOLAYERS BY BASIC FIBROBLAST GROWTH FACTOR-SAPORIN MITOTOXIN
    BEATTIE, GM
    LAPPI, DA
    BAIRD, A
    HAYEK, A
    [J]. DIABETES, 1990, 39 (08) : 1002 - 1005
  • [4] Bhlen P, 1990, PEPTIDE GROWTH FACTO, VI, P369
  • [5] CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620
  • [6] Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3
    Colvin, JS
    Bohne, BA
    Harding, GW
    McEwen, DG
    Ornitz, DM
    [J]. NATURE GENETICS, 1996, 12 (04) : 390 - 397
  • [7] MOLECULAR MECHANISMS OF ANGIOGENESIS - FIBROBLAST GROWTH-FACTOR SIGNAL-TRANSDUCTION
    FRIESEL, RE
    MACIAG, T
    [J]. FASEB JOURNAL, 1995, 9 (10) : 919 - 925
  • [8] Goldman CK, 1997, CANCER RES, V57, P1447
  • [9] CORPUS-LUTEUM ANGIOGENIC FACTOR IS RELATED TO FIBROBLAST GROWTH-FACTOR
    GOSPODAROWICZ, D
    CHENG, J
    LUI, GM
    BAIRD, A
    ESCH, F
    BOHLEN, P
    [J]. ENDOCRINOLOGY, 1985, 117 (06) : 2383 - 2391
  • [10] HAWKINS JE, 1976, HDB SENSORY PHYSIOLO, V5, P707